Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Aug 08, 2017 12:08pm
270 Views
Post# 26556496

RE:RE:RE:RE:RE:RE:RE:RE:RE:wake up to a new owner one day, soon!

RE:RE:RE:RE:RE:RE:RE:RE:RE:wake up to a new owner one day, soon! Hi, Francois,
Again my reply in yellow below:

Good day Stockman6767

I respect your comments and views...  Nice to interact with you...

1) Pure gambling : Agree with educated guessing but only 2-3 % of reasearch gives results (new molecule). So 2-3 % is a wild guess for me or a long shot or pure gambling (If I may say). Sure, at the start it was a long shot - but we are way past the initial long shot point by now, with quite a bit of both animal model and PI and PII results rolling in and about to start on PIII's not too far in the future for initial indications. so we may still be in significant risk situation with 4050, but we are way past the initial long shot - maybe now just a "middle shot"?

2) 5-6 $ : I will be way more then happy my friend, just not sure of the % I would sell... That would not be my price point - I have the luxury to be able to wait for a mature share price before selling. I might even choose to hold to see if good  dividends ever materialize maybe 8 -10 years down the road.  While I took FD's  overly rosy forecasting with a huge grain of salt for many reasons - nevertheless I do share his rosy picture of the future, if not all his numbers nor his timetable.

3) Only a small orphan indication of PG is near approval : Now, what about off label use for other applications. While I agree that off-label may be a significant factor down the road, it does not happen over night, and will take time to happen where feasible. Not every indication will be able to use the same formulation initially available etc.  The pricing model for PG may also get in the way of some off-lable use.  D'ont you think that the word will spread so fast (everywhere) that they will have problem to supply. Lots of people are waiting for this (PG) with very serious conditions in all indications (IMO)...  So no effect at all on profitability and SP ???   Like to hear from you or others on this... So yes, we all agree that eventually when more and larger indications are approved Pg will be a monster revenue producer and off-lbel will help us get there a little sooner - but not over night.  Glta. Stockman6767

IMO

Thanks !

Francois33
Bullboard Posts